Skip to main content

Cellect Biotechnology Ltd. (APOP)

NASDAQ: APOP · IEX Real-Time Price · USD
13.13
+0.12 (0.92%)
After-hours:Oct 22, 2021 7:33 PM EDT
13.01
-1.43 (-9.90%)
At close: Oct 22, 4:00 PM
Market Cap13.11M
Revenue (ttm)n/a
Net Income (ttm)-5.10M
Shares Out980,434
EPS (ttm)-0.85
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume103,633
Open14.00
Previous Close14.44
Day's Range13.01 - 14.00
52-Week Range6.60 - 35.52
Beta1.88
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About APOP

Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative d...

IndustryLife Sciences Tools & Services
Founded2011
Employees12
Stock ExchangeNASDAQ
Ticker SymbolAPOP
Full Company Profile

Financial Performance

Financial numbers in millions ILSFinancial Statements

News

Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Q...

Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs...

1 week ago - GlobeNewsWire

5 Short Squeeze Candidates To Watch: Aterian, Marin On List Again, Plus 3 New Small-Cap Medical Plays

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC), two stocks that attracted s...

Other symbols:ATERBMRAMRINPROG
2 weeks ago - Benzinga

Why Cellect Biotechnology Shares Are Rising Today

Cellect Biotechnology Ltd (NASDAQ: APOP) is trading higher Monday after the company announced shareholder approval of the strategic merger with Quoin Pharmaceuticals. Approximately 99% of the votes were...

3 weeks ago - Benzinga

Here's why Cellect Biotechnology shares are up 50% on Monday

Cellect Biotechnology Ltd (NASDAQ: APOP) shareholders approved the previously announced strategic merger agreement with Quoin Pharmaceuticals, the company said in a press release on Monday. Shares of th...

3 weeks ago - Invezz

Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals

Tel Aviv, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced shareholders voted to approve the previously announced strategic merger agreement with privately-held ...

3 weeks ago - GlobeNewsWire

See Why Cellect Biotechnology Stock Is Soaring During Premarket Friday

Cellect Biotechnology Ltd (NASDAQ: APOP) announced the first ApoGraft transplantation in a Leukemia patient in a clinical trial in the U.S.  ApoGraft is designed to prevent graft-versus-host disease (GV...

1 month ago - Benzinga

Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.

Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity EnCellX Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity En...

1 month ago - GlobeNewsWire

Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating Results

Strategic Merger Transaction Remains on Track to Close During the 2021 Third Quarter

1 month ago - GlobeNewsWire

The Securities and Exchange Commission Declared Cellect Biotechnology's Registration Statement Filed on Form F-4 Effe...

Special General Meeting of Shareholders Scheduled for September 19, 2021

2 months ago - GlobeNewsWire

Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist

Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other symbols:ACSTCHEKSEELWORX
3 months ago - PennyStocks

Short Squeeze Stocks: CLOV, AEI and 3 Other Stocks Experts Think Are Ready to Pop

Short squeeze stocks have been targeted quite a bit lately as retail traders tackle them in an effort to push out hedge funds. The post Short Squeeze Stocks: CLOV, AEI and 3 Other Stocks Experts Think A...

Other symbols:AEICLOVDBGIORPH
3 months ago - InvestorPlace

These Penny Stocks Are Up Big Today, Worth It or Not?

3 big gaining penny stocks today; are they worth it? The post These Penny Stocks Are Up Big Today, Worth It or Not?

Other symbols:EVFMJFU
4 months ago - PennyStocks

Why Are Cellect Biotechnology (APOP) Shares Surging Today?

Cellect Biotechnology Ltd (NASDAQ: APOP) has filed a registration statement with the SEC in connection with its proposed strategic merger with privately-held Quoin Pharmaceuticals Inc. See the SEC regis...

4 months ago - Benzinga

Cellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin ...

Transaction Expected to Close in the 2021 Third Quarter Transaction Expected to Close in the 2021 Third Quarter

4 months ago - GlobeNewsWire

Are These Penny Stocks The Biggest Morning Movers?

These penny stocks moved in early morning trading; will you add them to your watchlist? The post Are These Penny Stocks The Biggest Morning Movers?

Other symbols:BORREYES
5 months ago - PennyStocks

5 Hot Penny Stocks To Buy? Check These Out For May 2021

Looking for the best penny stocks in May 2021? Check these 5 out The post 5 Hot Penny Stocks To Buy?

Other symbols:ATOSEVFMXXII
5 months ago - PennyStocks

Market Update: The 10 Most Volatile Stocks Today

Joins us as we take a look at the most volatile stocks for Monday as many shares see their prices fluctuate during the day. The post Market Update: The 10 Most Volatile Stocks Today appeared first on In...

5 months ago - InvestorPlace

Cellect Bio's ApoGraft Therapy Is Safe, Tolerable In GvHD Study

Cellect Biotechnology Ltd (NASDAQ: APOP) has announced data from the Phase 1/2 study in Israel evaluating ApoGraft technology for Graft versus Host Disease (GvHD), a severe complication of allogeneic he...

6 months ago - Benzinga

Cellect Biotechnology Reports Fourth Quarter and Full Year 2020 Financial and Operating Results

TEL AVIV, Israel, March 29, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”), a developer of innovative technology that enables the functional selection of stem cells, today reported...

6 months ago - GlobeNewsWire

Why Cellect, Immutep, F-star, ProQR and Evofem Are Moving Thursday

Cellect Biotechnology Ltd. (NASDAQ: APOP), Immutep Limited (NASDAQ: IMMP), F-star Therapeutics, Inc. (NASDAQ: FSTX), ProQR Therapeutics N.V.

Other symbols:EVFMFSTXIMMPPRQR
6 months ago - Benzinga

Why PRQR Stock And APOP Stock Are Popping Off Today

ProQR Therapeutics NV (NASDAQ: PRQR) shares are trading higher by more than 52% after the company reported results Wednesday from its trial of QR-421a in Usher Syndrome, though the stock did not surge i...

Other symbols:PRQR
6 months ago - Benzinga

APOP Stock: Why Cellect Biotechnology Is Skyrocketing Today

APOP stock holders are getting a 1:3 ratio of shares in the tie-up deal. The merger brings together Cellect's stem cell tech with Quoin's rare and orphan diseases focus.

6 months ago - InvestorPlace

Today's Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning

Pre-market movers this morning include some high-profile top gainers and losers. Take a look at this list that includes NFT stocks and EV plays.

6 months ago - InvestorPlace

Cellect Biotechnology and Quoin Pharmaceuticals Announce Strategic Merger

Up to $25 million of funding at $75 million pre-money valuation to be available to the combined company concurrently with the merger

6 months ago - GlobeNewsWire

Cellect Biotechnology Reports Third Quarter Financial and Operating Results; Recent Developments Position Company to ...

Promising Progress on Clinical D evelopment Progress , Collaboration s and Partnering

11 months ago - GlobeNewsWire